Dwight Reynolds to Prospective Studies
This is a "connection" page, showing publications Dwight Reynolds has written about Prospective Studies.
Connection Strength
0.909
-
A Leadless Intracardiac Transcatheter Pacing System. N Engl J Med. 2016 Feb 11; 374(6):533-41.
Score: 0.099
-
Race and improvements in the use of guideline-recommended therapies for patients with heart failure: findings from IMPROVE HF. J Natl Med Assoc. 2012 May-Jun; 104(5-6):287-98.
Score: 0.077
-
Interventions in the diagnosis and adoption of pacemaker therapy in sinus node dysfunction patients: Results from the IMPROVE Brady study. Indian Heart J. 2022 Sep-Oct; 74(5):351-356.
Score: 0.040
-
Development and validation of a risk score for predicting pericardial effusion in patients undergoing leadless pacemaker implantation: experience with the Micra transcatheter pacemaker. Europace. 2022 07 21; 24(7):1119-1126.
Score: 0.039
-
Patient selection, pacing indications, and subsequent outcomes with de novo leadless single-chamber VVI pacing. Europace. 2019 Nov 01; 21(11):1686-1693.
Score: 0.033
-
Health-related quality of life impact of a transcatheter pacing system. J Cardiovasc Electrophysiol. 2018 12; 29(12):1697-1704.
Score: 0.030
-
Physical activity detection in patients with intracardiac leadless pacemaker. J Cardiovasc Electrophysiol. 2018 12; 29(12):1690-1696.
Score: 0.030
-
To retrieve, or not to retrieve: System revisions with the Micra transcatheter pacemaker. Heart Rhythm. 2017 12; 14(12):1801-1806.
Score: 0.028
-
Contractility sensor-guided optimization of cardiac resynchronization therapy: results from the RESPOND-CRT trial. Eur Heart J. 2017 Mar 07; 38(10):730-738.
Score: 0.027
-
Long-term performance of a transcatheter pacing system: 12-Month results from the Micra Transcatheter Pacing Study. Heart Rhythm. 2017 05; 14(5):702-709.
Score: 0.027
-
Early performance of a miniaturized leadless cardiac pacemaker: the Micra Transcatheter Pacing Study. Eur Heart J. 2015 Oct 01; 36(37):2510-9.
Score: 0.024
-
The rationale and design of the Micra Transcatheter Pacing Study: safety and efficacy of a novel miniaturized pacemaker. Europace. 2015 May; 17(5):807-13.
Score: 0.024
-
Clinical effectiveness of CRT and ICD therapy in heart failure patients by racial/ethnic classification: insights from the IMPROVE HF registry. J Am Coll Cardiol. 2014 Aug 26; 64(8):797-807.
Score: 0.023
-
Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF. Circ Heart Fail. 2014 Jan; 7(1):146-53.
Score: 0.021
-
The Registry Evaluating Functional Outcomes of Resynchronization Management (REFORM): quality of life and psychological functioning in patients receiving cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2014 Jan; 25(1):43-51.
Score: 0.021
-
Factors associated with improvement in utilization of cardiac resynchronization therapy in eligible heart failure patients: findings from IMPROVE HF. Pacing Clin Electrophysiol. 2013 Apr; 36(4):433-43.
Score: 0.020
-
B-type natriuretic peptide assessment in ambulatory heart failure patients: insights from IMPROVE HF. J Cardiovasc Med (Hagerstown). 2012 Jun; 13(6):360-7.
Score: 0.019
-
Lack of association between electronic health record systems and improvement in use of evidence-based heart failure therapies in outpatient cardiology practices. Clin Cardiol. 2012 Mar; 35(3):187-96.
Score: 0.019
-
Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: findings from IMPROVE HF. Am Heart J. 2012 Jan; 163(1):49-56.e2.
Score: 0.019
-
Medication dosing in outpatients with heart failure after implementation of a practice-based performance improvement intervention: findings from IMPROVE HF. Congest Heart Fail. 2012 Jan-Feb; 18(1):9-17.
Score: 0.019
-
Associations between outpatient heart failure process-of-care measures and mortality. Circulation. 2011 Apr 19; 123(15):1601-10.
Score: 0.018
-
patient and practice factors associated with improvement in use of guideline-recommended therapies for outpatients with heart failure (from the IMPROVE HF trial). Am J Cardiol. 2011 Jan 15; 107(2):250-8.
Score: 0.018
-
Equitable improvement for women and men in the use of guideline-recommended therapies for heart failure: findings from IMPROVE HF. J Card Fail. 2010 Dec; 16(12):940-9.
Score: 0.018
-
Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). Circulation. 2010 Aug 10; 122(6):585-96.
Score: 0.017
-
Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF. Circ Heart Fail. 2010 Sep; 3(5):596-605.
Score: 0.017
-
Outpatient cardiology practices with advanced practice nurses and physician assistants provide similar delivery of recommended therapies (findings from IMPROVE HF). Am J Cardiol. 2010 Jun 15; 105(12):1773-9.
Score: 0.017
-
Electronic health records and quality of care for heart failure. Am Heart J. 2010 Apr; 159(4):635-642.e1.
Score: 0.017
-
Influence of renal function on the use of guideline-recommended therapies for patients with heart failure. Am J Cardiol. 2010 Apr 15; 105(8):1140-6.
Score: 0.017
-
Influence of dedicated heart failure clinics on delivery of recommended therapies in outpatient cardiology practices: findings from the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). Am Heart J. 2010 Feb; 159(2):238-44.
Score: 0.017
-
Cardiac resynchronization therapy utilization for heart failure: findings from IMPROVE HF. Am Heart J. 2009 Dec; 158(6):956-64.
Score: 0.016
-
Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post-myocardial infarction left ventricular dysfunction: Findings from IMPROVE HF. Heart Rhythm. 2009 Dec; 6(12):1727-34.
Score: 0.016
-
Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Am Heart J. 2009 Apr; 157(4):754-62.e2.
Score: 0.016
-
Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Circ Heart Fail. 2008 Jul; 1(2):98-106.
Score: 0.015
-
Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry. Am Heart J. 2007 Jul; 154(1):12-38.
Score: 0.014
-
Implant experience with an implantable hemodynamic monitor for the management of symptomatic heart failure. Pacing Clin Electrophysiol. 2005 Aug; 28(8):747-53.
Score: 0.012
-
Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system. J Am Coll Cardiol. 2003 Feb 19; 41(4):565-71.
Score: 0.010
-
Continuous ambulatory right heart pressure measurements with an implantable hemodynamic monitor: a multicenter, 12-month follow-up study of patients with chronic heart failure. J Card Fail. 2002 Apr; 8(2):63-70.
Score: 0.010
-
Interference with cardiac pacemakers by cellular telephones. N Engl J Med. 1997 May 22; 336(21):1473-9.
Score: 0.007